切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2023, Vol. 17 ›› Issue (06) : 706 -710. doi: 10.3877/cma.j.issn.1674-0785.2023.06.014

临床研究

甲状旁腺切除对继发性甲状旁腺功能亢进患者骨密度及骨代谢的影响
周加军, 余永武, 周涵, 刘勇(), 张凌()   
  1. 241000 芜湖,皖南医学院第一附属医院血液净化中心
    100022 北京,清华大学附属垂杨柳医院肾内科
    330000 南昌,南昌大学玛丽女王学院
    100029 北京,中日友好医院肾内科
  • 收稿日期:2022-05-24 出版日期:2023-06-15
  • 通信作者: 刘勇, 张凌
  • 基金资助:
    芜湖市科技民生专项基金(2020ms3-6); 皖南医学院弋矶山医院引进人才项 目(YR201921)

Impact of parathyroidectomy on bone mineral density and bone metabolism in patients with secondary hyperparathyroidism

Jiajun Zhou, Yongwu Yu, Han Zhou, Ling Zhang()   

  1. Department of Rheumatology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan 030032, China
    Department of Nephrology, the Affiliated Hospital of Tsinghua University, Beijing 100022, China
    Queen Mary College of Nanchang University, Nanchang 330000, China
    Department of Nephrology, China-Japan Friendship Hospital, Beijing 100029, China
  • Received:2022-05-24 Published:2023-06-15
  • Corresponding author: Ling Zhang
引用本文:

周加军, 余永武, 周涵, 刘勇, 张凌. 甲状旁腺切除对继发性甲状旁腺功能亢进患者骨密度及骨代谢的影响[J]. 中华临床医师杂志(电子版), 2023, 17(06): 706-710.

Jiajun Zhou, Yongwu Yu, Han Zhou, Ling Zhang. Impact of parathyroidectomy on bone mineral density and bone metabolism in patients with secondary hyperparathyroidism[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 706-710.

目的

探讨甲状旁腺切除术对继发性甲状旁腺功能亢进患者骨密度及骨代谢的影响。

方法

回顾性分析2015年7至2017年7月在中日友好医院接受甲状旁腺切除术的61例继发性甲状旁腺功能亢进患者的临床资料,观察术前、术后第1天及术后1年患者的骨密度(BMD)及骨代谢指标的变化情况。

结果

术后第1天患者的血钙、全段甲状旁腺激素(iPTH)较术前明显降低(P<0.001),血磷、碱性磷酸酶(ALP)手术前后变化不明显(均P>0.05)。术后1年患者的抗酒石酸酸性磷酸酶(TRACP)由术前6.90(4.69,10.28)U/L降至2.50(1.97,3.13)U/L,差异有统计学意义(P<0.001);CTX-I由术前的2.27(1.46,3.05)μg/L降至0.36(0.23,0.96)μg/L,差异有统计学意义(P<0.001);P1NP由术前1062(438,1200)μg/L降低至169(116,342)μg/L,差异有统计学意义(P<0.001);BAP由术前60.00(33.36,90.00)μg/L降至12.44(10.95,16.48)μg/L,差异有统计学意义(P<0.001);但N-MID-OC术前术后变化不明显(P=0.499)。术后1年L1-4 BMD由1.02 g/cm2升至1.14 g/cm2,差异有统计学意义(P=0.002);L1-4 T值由术前-0.76±1.70升至0.28±1.70,差异有统计学意义(P<0.001);全髋BMD及T值术后交术前均明显升高,分别由0.76(0.67,0.88)g/cm2升高至0.87(0.76,1.00)和由-1.70(-2.40,-0.80)升高至-0.75(-1.52,0.20),差异均有统计学意义(均P<0.001)。

结论

甲状旁腺切除术可以改善继发性甲状旁腺功能亢进患者骨代谢状态,增加患者骨密度。

Objective

To investigate the effect of parathyroidectomy on bone mineral density and bone metabolism in patients with secondary hyperparathyroidism.

Methods

The clinical data of 61 patients with secondary hyperparathyroidism who underwent parathyroidectomy at China-Japan Friendship Hospital from July 2015 to July 2017 were retrospectively analyzed. The changes in bone mineral density and bone metabolism indexes before and one year after surgery were investigated.

Results

On the first day post-operation, the levels of blood calcium and intact parathyroid hormone (iPTH) significantly decreased (P<0.001 for both), while the changes in blood phosphorus and alkaline phosphatase (ALP) after surgery were not significant (P>0.05 for both). One year after surgery, the serum tartrate resistant acid phosphatase (TRACP) levels of the patients decreased from 6.90 (4.69, 10.28) U/L to 2.50 (1.97, 3.13) U/L (P<0.001); the serum C-terminal cross-linked peptide of collagen type I (CTX-I) levels decreased from 2.27(1.46, 3.05) μg/L before the operation to 0.36 (0.23, 0.96) μg/L (P<0.001); serum procollagen type 1 aminoterminal propeptide (P1NP) levels decreased from 1062.00 (438.30, 1200.00) μg/L to 168.70 (116.30, 342.00) μg/L (P<0.001); serum bone-specific alkaline phosphatase (BAP) levels decreased from 60.00 (33.36, 90.00) μg/L to 12.44 (10.95, 16.48) μg/L (P<0.001); however, there was no significant change in serum N-terminal midfragment of osteocalcin (N-MID-OC) before and after operation (P=0.499). One year after surgery, the bone mineral density (BMD) of lumbar spine 1-4 (L1-4) increased from 1.02 g/cm2 to 1.14 g/cm2 (P=0.002); L1-4 T score increased from -0.76±1.70 to 0.28±1.70 (P<0.001); the total hip BMD and T score increased significantly from 0.76 (0.67, 0.88) g/cm2 to 0.87 (0.76, 1.00) g/cm2, and from -1.70 (-2.40, -0.80) to -0.75 (-1.52, 0.20), respectively (P<0.001 for both).

Conclusion

Parathyroidectomy can improve bone metabolism and increase bone mineral density in patients with secondary hyperparathyroidism.

表1 继发性甲状旁腺功能亢进症患者的一般临床资料
表2 继发性甲状旁腺功能亢进症患者甲状旁腺切除术后第1天生化指标及iPTH、ALP的变化情况
表3 继发性甲状旁腺功能亢进症患者甲状旁腺切除术后1年骨代谢指标的变化情况比较[MQ1Q3)]
表4 继发性甲状旁腺功能亢进症患者甲状旁腺切除术后1年骨密度的变化情况比较
1
Muppidi V, Meegada SR, Rehman A. Secondary Hyperparathyroidism [M]. Treasure Island: StatPearls Publishing, 2022.
2
Steinl GK, Kuo JH. Surgical management of secondary hyperparathyroidism [J]. Kidney Int Rep, 2021, 6(2): 254-264.
3
Rodríguez-Ortiz ME, Pendón-Ruiz de Mier MV, Rodríguez M. Parathyroidectomy in dialysis patients: Indications, methods, and consequences [J]. Semin Dial, 2019, 32(5): 444-451.
4
Ivarsson KM, Akaberi S, Isaksson E, et al. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism [J]. Nephrol Dial Transplant, 2015, 30(12): 2027-33.
5
张凌. 继发性甲状旁腺功能亢进的治疗策略 [J].中华肾病研究电子杂志, 2015, 4(3): 118-122.
6
Ge Y, Yang G, Wang N, et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism [J]. Int Urol Nephrol, 2019, 51(8): 1443-1449.
7
Neves KR, Graciolli FG, dos Reis LM, et al. Vascular calcification: contribution of parathyroid hormone in renal failure [J]. Kidney Int, 2007, 71(12): 1262-1270.
8
Sr HE, Eledrisi M, Khan F, et al. Secondary hyperparathyroidism in chronic kidney disease: pathophysiology and management [J]. Cureus, 2021, 13(7): e16388.
9
Ge Y, Yang G, Wang N, et al. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism [J]. Int Urol Nephrol, 2019,51(8):1443-1449.
10
杨光, 王宁宁, 葛益飞, 等. 尿毒症继发甲状旁腺功能亢进症患者甲状旁腺切除术后骨转换标志物的短期变化 [J].中华肾脏病杂志, 2017, 33(10): 750-756.
11
葛益飞, 杨光, 王宁宁, 等. 继发性甲状旁腺功能亢进患者甲状旁腺切除术后骨代谢标志物的短期变化 [J].中国血液净化, 2018, 17(9): 588-592.
12
徐勤, 张丽娜, 张振华, 等. 肾性继发性甲状旁腺功能亢进患者甲状旁腺切除手术前后骨代谢标志物水平变化 [J].中华实用诊断与治疗杂志, 2019, 33(12): 1181-1184.
13
Yajima A, Inaba M, Tominaga Y, et al. Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism [J]. J Bone Miner Res, 2010, 25(11): 2374-2381.
[1] 谭钝, 蔡慧, 李贵求, 苏飞军, 潘祺, 雷毅, 童作明. 小核仁RNA宿主基因7和微小RNA-449a在膝骨关节炎的表达[J]. 中华关节外科杂志(电子版), 2022, 16(06): 683-689.
[2] 李书振, 秦煜, 王豪, 曾沣, 梁海波, 尹东. 骨质疏松对全膝关节置换术后失血量的影响[J]. 中华关节外科杂志(电子版), 2022, 16(03): 369-372.
[3] 杨霁, 黄顺梅, 王安鸽, 吴月, 杨云梅. 杭州地区老年人群中肌少症患病情况及其与骨质疏松症的相关性分析[J]. 中华危重症医学杂志(电子版), 2023, 16(03): 207-210.
[4] 陈跃圻, 罗睿, 向涵, 余泳妍, 余挺. 骨质疏松症与牙周炎的因果关系:一项两样本孟德尔随机化研究[J]. 中华口腔医学研究杂志(电子版), 2023, 17(04): 292-298.
[5] 南方护骨联盟前列腺癌骨转移专家组. 前列腺癌骨转移诊疗专家共识(2023版)[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 201-208.
[6] 刘文, 罗丹, 代小雨, 鲜于剑波, 于颖娟, 钟春林, 王东. 继发性甲状旁腺功能亢进的治疗研究进展[J]. 中华肾病研究电子杂志, 2022, 11(05): 281-284.
[7] 刘思梦, 陈思, 周梦, 李青, 吴琳, 袁杨刚, 张波, 王宁宁, 张莉, 毛慧娟, 邢昌赢. 2021年肾脏病学基础研究进展[J]. 中华肾病研究电子杂志, 2022, 11(02): 79-83.
[8] 张茜, 刘叶青, 康雪莹, 孙兵兵, 刘岩, 胡丽叶, 周亚茹. 血清铁蛋白与绝经后骨质疏松症的相关性分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(03): 166-171.
[9] 覃成禹, 周昊楠, 陈远明. 葛根素对绝经后骨质疏松大鼠不同部位骨骼的抗骨质疏松作用差异的研究[J]. 中华老年骨科与康复电子杂志, 2023, 09(01): 23-27.
[10] 周冉冉, 赵小芹, 王鑫蕾, 袁洁, 周曹慧, 刘雅克. FRAX、OSTA与骨代谢指标在评价绝经后2型糖尿病患者骨密度中的临床价值[J]. 中华老年骨科与康复电子杂志, 2022, 08(04): 237-242.
[11] 田明达, 吴珺, 王会娟, 张欣, 沙玉英, 陈琳, 赵宾洋. 6297名0~3岁婴幼儿超声骨密度检测结果分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 644-647.
[12] 周加军, 余永武, 周涵, 张凌. 358例继发性甲状旁腺功能亢进症患者异位甲状旁腺的检出及分布情况分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 381-385.
[13] 王喜平, 徐旭, 蒋莉, 徐露莲, 顾克凤, 刘珍珍, 陆杨. 碳酸钙D3片联合亮丙瑞林对中枢性性早熟女童性激素和骨代谢的影响[J]. 中华临床医师杂志(电子版), 2022, 16(10): 965-969.
[14] 丁丽萍, 宋黎刚, 李一鑫, 刘子琪, 周明爽, 周菲, 张雪. 2型糖尿病患者25-羟维生素D水平与糖尿病微血管病变及骨代谢指标相关性分析[J]. 中华临床医师杂志(电子版), 2022, 16(05): 431-435.
[15] 戚晓阳, 杨平, 杜忠秋, 邱旭升, 汤黎明, 陈一心. 袖状胃切除术对肥胖合并2型糖尿病大鼠模型骨密度的影响[J]. 中华肥胖与代谢病电子杂志, 2023, 09(02): 102-108.
阅读次数
全文


摘要